Startup Valuation Methods & Multiples: Reading the Table Like a Poker Hand
Startup valuation methods and multiples are less like solving a sum and more like sizing up a poker hand. Here's how to read the table and bet a number you can back.
Startup valuation is the price an investor agrees to pay for a share of a company nobody can value with a clean sum, and that is why it feels less like accounting and more like a hand of poker. Nobody at the table can see the future. Each player works from the cards they can read, the bet sizes around the table, and a belief about what is coming on the river. The number on the term sheet is a bet, not a fact.
That framing changes how you should walk into the room.
In poker you do not know your opponent’s cards. You play a game of imperfect information, sizing up a hand from outs, position, and how the other player bets. Startup valuation works the same way. The investor cannot see your revenue five years out any more than you can. So both of you reach for a method that turns guesses into a number you can defend, then you bet. A founder who reads the table walks in with a price in mind. A founder who cannot read it gets read instead, and tends to accept whatever number the investor opens with.
Most founders accept that number without knowing they had a choice.
Why startup valuation is a bet, not a sum
A public company has a price quoted on a stock market, available frequently. A private startup does not. It isn’t listed anywhere, and its value sits on potential for growth and possible future profits, not on assets or current income you can read off a balance sheet.
That is why pre-revenue valuation feels unscientific. You are selling a belief about a hand still being dealt, and the methods are different ways to size up the same young company. One study reported in the Harvard Business Review found that venture capitalists rarely use standard financial analytics, and that 95% of firms surveyed cite the founder or founding team as the most important factor in the decision.
The math is real, but it sits under the story, the way pot odds sit under a player’s read of the room. Your job is to make the belief credible with evidence. The investor’s job is to anchor you low using the method that flatters their position. Both of you are betting. The founder who knows which method fits the stage prices the pot instead of calling a number handed across the table.
The founder who knows which method fits the stage prices the pot instead of calling a number handed across the table.
The methods, sized up like hands at the table
Each method is a different read on the same company. Below is what each one does and the inputs it needs.
Comparables and multiples
This is the relative read. It prices your company by observing recent deals for similar firms, then pulls a multiple from those prices, such as price-to-sales or price-to-earnings, and applies it to your own number. For an early-stage startup with thin revenue, the multiple often runs on sales rather than profit, or on a usable factor like price-per-user. The average pre-money valuation in your sector, drawn from current deals, sets the reference points. It’s the closest thing to checking the bet sizes around the table before you act.
Scorecard-style adjustment
This one opens from the average pre-money valuation of pre-revenue startups in the same market, then raises or lowers based on your qualities: team, traction, market size, product. It is comparison with judgment layered on top, and it is the most common honest read for pre-seed, because it admits each startup is unique while still anchoring to current market data. Think of it as adjusting your bet for position and reads, not just the cards.
The venture method
Investors who fund startups care about one thing above all: the cash returned as a multiple of the cash invested. The venture method works the hand back to front. You estimate what the company could sell for at an exit, an IPO or acquisition, apply the return the investor wants, and discount that back to today. It builds in the high risk of betting this early.
Discounted cash flow
This prices value from expected future cash flows, discounted to the present. The riskier the company, the higher the discount rate, the lower the value. The method looks precise on paper and burns you on a startup, because the inputs are guesses dressed as projections. Model inputs vary a lot with judgment and differing assumptions. Use it as a check on your read, not the main read, until you have actual numbers to feed it.
Net asset value
The floor. A solvent company could shut down, sell its assets, pay creditors, and whatever cash is left sets a minimum value. For most startups this is irrelevant, because the value lives in potential, not in tangible assets. It only matters when a company is worth more out of the game than in it.
Which method fits which stage
Position changes how you bet, and stage changes which method the table reaches for.
| Stage | Reach for | Why |
|---|---|---|
| Pre-seed | Scorecard-style adjustment, comparables | No revenue to multiply; you anchor to market deals and adjust on team and traction |
| Seed | Comparables, the venture method | Some traction; investors price the exit and the multiple they need on it |
| Series A | Multiples, the venture method, early discounted cash flow | Real revenue appears; reported valuations often land between $10 million and $15 million |
| Growth (Series B and later) | Multiples, discounted cash flow | Traction is proven and the bet is lower risk, so the math carries more weight |
I watched a founder named Priya walk into a seed round last spring with one number she had read off a single comparable deal. The investor opened with the venture method, priced her exit low, and she had no second read to answer with. She gave up a third of her company in under twenty minutes, because she had nothing to push back with before the real betting even started.
Frequently asked questions
How do you value a startup with no revenue?
You don’t run the numbers, because there are no numbers worth multiplying. You open from the average pre-money valuation of comparable pre-revenue startups in your market, then adjust on team, traction, and market potential. The story carries the value, and your evidence makes the story credible.
What multiple do startups use for valuation?
Whichever the company can support. Mature firms lean on price-to-earnings. Early-stage startups with little profit lean on a price-to-sales multiple, or a usable factor like price-per-user. The multiple comes from recent deals for similar firms, applied to your own metric.
Why do two investors value the same startup differently?
Because valuation is a bet on the future, and the inputs need judgment. A different method, a different set of assumptions, or a different read on the team will produce a different number. The same company can be priced high by one investor and low by another, and neither is wrong. That gap is where the negotiation happens, the same way two players will price the same pot differently.
Is discounted cash flow useful for early-stage startups?
Rarely as the main read. Its inputs are projections you can’t prove yet, so it produces a precise number built on guesses. It earns its position at growth stage, when actual cash flows exist. Early on, treat it as a sanity check on the venture method, not the answer.
The stand
Most founders learn one valuation method, usually the wrong one for their stage, then get anchored by whatever number the investor opens with. There is no true formula to go find. The fix is to read the whole table, so you can price the pot at your stage and back your number when the room raises.
Every method here runs on inputs, and those inputs come from knowing your own cash. You cannot back a valuation with evidence you do not track. That is the part founders control, and the part CX Cash was built for. When you know where the money is going, the story you tell investors is backed by numbers you can defend. Grab the investor update template and the cap table and dilution calculator, join CX Cash before launch, and share this with the founder down the hall who is still betting on a discounted cash flow model for a company with no cash flow.
More in Startup Fundraising, Runway & Equity
Option Pool Sizing: Clear the Bed Before You Plant, Not After
An option pool is equity you set aside for future hires. Size your option pool like a garden bed: to what you will actually plant, not to a template a blog handed you.
Term Sheet Explained: Read It Like a Bridge You Have to Walk Across
Term sheet explained for founders: treat the document like a bridge you'll cross on your worst day. Here's how to test the deck, the cables, and the supports before you sign.
409A Valuation, Explained: Reading Your Startup's Vital Signs
A plain 409a valuation guide for founders: think of it as the vital signs an independent doctor reads on your common stock, why a low reading is healthy, and how it protects your team.